Biotechnology

Angelini Ventures co-leads €20m Series A to advance RNA therapeutics for neurological disorders
  1. Biotechnology

Angelini Ventures co-leads €20m Series A to advance RNA therapeutics for neurological disorders

Copenhagen-based biotech Neumirna Therapeutics has secured €20 million in a Series A funding round co-led by Angelini Ventures and Invivo Partners, with participation from Innovestor’s Life Science Fund and existing investors. The funding will advance Neumirna’s pioneering RNA therapeutics pipeline, including its lead candidate NMT.001, an antisense oligonucleotide (ASO) therapy targeting drug-resistant epilepsy. Founded in […]
Written by
New tentative approval for Alembic drug dabigatran etexilate mesylate
  1. Biotechnology

New patent for Arcutis drug ZORYVE

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Annual Drug Patent Expirations for ZORYVE Zoryve is a drug marketed by Arcutis and is included in two NDAs. It is available from one supplier. There are seven patents protecting this drug. ZORYVE drug price trends. This drug has forty-two patent family members in twelve countries. The generic […]
Written by
Breakthrough Cerium Oxide Thermal Switches
  1. Biotechnology

Breakthrough Cerium Oxide Thermal Switches

In a significant breakthrough that could redefine thermal management systems, researchers from Hokkaido University have introduced a remarkable advancement in thermal switches utilizing cerium oxide. This innovative approach, which leverages thin films of cerium oxide (CeO2), promises not just enhanced performance but also a sustainable alternative to traditional materials that have long constrained the effectiveness […]
Written by
Challenging the European biotech funding status quo
  1. Biotechnology

[Rebroadcast] The power of natural killer cells

While our podcast takes a brief break, Labiotech invites you to enjoy some of our favorite episodes. We will return with a brand-new episode on January 3rd, 2025! Have an awesome holiday season! On this podcast, we speak to Artiva Biotherapeutics’ CEO, Fred Aslan, M.D. The company has demonstrated the potential for efficacy and safety […]
Written by
New tentative approval for Alembic drug dabigatran etexilate mesylate
  1. Biotechnology

New patent for Vanda Pharms drug HETLIOZ

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two NDAs. It is available from one supplier. There are thirty patents protecting this drug and two Paragraph IV challenges. Drug patent litigation for HETLIOZ. This drug has one […]
Written by
Elevation Oncology Inc licences Synaffix BV's ADC platform
  1. Biotechnology

Elevation Oncology Inc licences Synaffix BV’s ADC platform

With the US$368m licence deal, Elevation Oncology, Inc is recognising Synaffix’s expertise in ADC development for the development of EO-1022. In contrast to Synaffix’s November deal with the Chinese BigHat Bioscience Co. Ltd, the US company does not book Lonza’s ADC manufacturing services that offers the same quality assurance process for all (clinicla) development phases, […]
Written by

Good Reads

Merbecovirus S2 Vaccines Trigger Cross-Reactive MERS Protection

In a groundbreaking study recently published in npj Viruses, a team of researchers led by Halfmann and colleagues has unveiled promising new insights into vaccine design against Merbecoviruses, a subgenus of coronaviruses that includes the Middle East Respiratory Syndrome coronavirus (MERS-CoV). Their work focuses on the S2 subunit of the spike (S) glycoprotein, a component […]
Written by

Worlwide

Merbecovirus S2 Vaccines Trigger Cross-Reactive MERS Protection

In a groundbreaking study recently published in npj Viruses, a team of researchers led by Halfmann and colleagues has unveiled promising new insights into vaccine design against Merbecoviruses, a subgenus of coronaviruses that includes the Middle East Respiratory Syndrome coronavirus (MERS-CoV). Their work focuses on the S2 subunit of the spike (S) glycoprotein, a component […]
Written by

Bridging Science, Policy and Strategy for Climate Action – State of the Planet

Tiffany Wu, a 2023 graduate of Columbia University’s MPA in Environmental Science and Policy program, is a senior program associate at Winrock International, which provides solutions to complex social and agricultural challenges worldwide. Wu works on climate and sustainability projects spanning carbon markets, corporate greenhouse gas accounting and clean energy. Courtesy of Tiffany Wu Drawing […]
Written by

Trending

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.